New hope for chemo patients: trial aims to stop debilitating nausea
NCT ID NCT07413809
Summary
This study is comparing two different combinations of anti-nausea medications to see which one works better at preventing severe, delayed nausea and vomiting in multiple myeloma patients undergoing high-dose chemotherapy and a stem cell transplant. It involves 92 patients across 11 hospitals who are randomly assigned to receive one of the two drug regimens. The goal is to find a more effective way to control these difficult side effects and improve patients' quality of life during this intense treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Affiliated People's Hospital of Ningbo University
RECRUITINGNingbo, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.